Strategies for discovering novel cancer biomarkers through utilization of emerging technologies (Q37241749)

19 August 2017

1 reference

title

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies (English)

1 reference

19 August 2017

0 references

Eleftherios P. Diamandis

series ordinal

2

object named as

Eleftherios P Diamandis

1 reference

19 August 2017

Vathany Kulasingam

1

0 references

publication date

12 August 2008

1 reference

Nature Clinical Practice Oncology

19 August 2017

1 reference

19 August 2017

5

1 reference

19 August 2017

588-599

1 reference

19 August 2017

10

1 reference

Serum proteomic patterns for detection of prostate cancer

19 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

The case for early detection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

On a New Substance Occurring in the Urine of a Patient with Mollities Ossium

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Production of embryonal alpha-globulin by transplantable mouse hepatomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Specific carcinoembryonic antigens of the human digestive system

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Reactivity of a monoclonal antibody with human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

The human plasma proteome: history, character, and diagnostic prospects

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Comprehensive analysis of HE4 expression in normal and malignant human tissues

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Biological implications of SNPs in signal peptide domains of human proteins

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Cellular aspects of alpha-fetoprotein reexpression in tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Lymphangiogenesis and cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Microarray analysis and tumor classification

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Cluster analysis and display of genome-wide expression patterns

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Towards a novel classification of human malignancies based on gene expression patterns

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Prediction of central nervous system embryonal tumour outcome based on gene expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Predicting individual outcomes in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

A five-gene signature and clinical outcome in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

A perspective on DNA microarrays in pathology research and practice

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Prediction of cancer outcome with microarrays: a multiple random validation strategy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Microarrays and molecular research: noise discovery?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Mass spectrometry and protein analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Proteomic approaches to the diagnosis, treatment, and monitoring of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Identification of patients with head and neck cancer using serum protein profiles

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Lessons from controversy: ovarian cancer screening and serum proteomics.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Clinical proteomics: Written in blood

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Characterization of the low molecular weight human serum proteome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Accurate mass measurement and tandem mass spectrometry of intact globin chains identify the low proportion variant hemoglobin Lepore-Boston-Washington from the blood of a heterozygote.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Differential exoprotease activities confer tumor-specific serum peptidome patterns

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Peptidomics for cancer diagnosis: present and future

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

The emerging roles of human tissue kallikreins in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

The microenvironment of the tumour-host interface

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

The role of the microenvironment and intercellular cross-talk in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Autoantibody signatures in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Proteomic patterns of tumour subsets in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Discovery of cancer biomarkers through the use of mouse models

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Phases of biomarker development for early detection of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Early Diagnosis of Medullary Carcinoma of the Thyroid Gland by Means of Calcitonin Assay

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Colorectal carcinoma antigens detected by hybridoma antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Biomarkers in cancer staging, prognosis and treatment selection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Current status of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Markers in gynaecological cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Searching for pathogenic epitopes in thyroglobulin: parameters and caveats

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1187

7 January 2021

Identifiers

DOI

10.1038/NCPONC1187

1 reference

19 August 2017

1 reference

PubMed ID

18695711